Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) technology uses MRI brain scan data to support early and differential diagnosis, track progression, and predict the decline of neurodegenerative diseases. Oxford Brain Diagnostics is committed to assessing brain health based on changes in the cellular structure, supporting drug development, and helping clinicians around the world in their fight to defeat Alzheimer’s and other neurodegenerative diseases.


Health Data

Life Sciences

Medical Devices

Oxford Brain Diagnostics Ltd

Steven Chance

Daniel Kaute

Nao Kamiya

Terry Pollard

Omar Ehsan

Ian Hardingham

Ged Ridgway

The Engineering and Science team at Oxford Brain Diagnostics Ltd is responsible for the development, implementation, and optimization of the company’s patented Cortical Disarray Measurement (CDM®) technology. They work on integrating and analyzing MRI brain scan data to support the early and differential diagnosis of neurodegenerative diseases, track their progression, and predict decline. This team combines expertise in software development and scientific research to drive innovation in brain health assessment and support drug development efforts.

Engineering and Science

Leadership Team

Engineering and Science

About

Team members

Other teams at Oxford Brain Diagnostics Ltd

Leadership Team